INTRODUCTION
There are two different types of adipose cells in mammals, white adipocytes and brown adipocytes. In contrast to the primarily fat-storing function of white adipose tissue (WAT), brown adipose tissue (BAT) has non-shivering, thermogenic properties due to the expression of the UCP1 and increased mitochondrial content (Ravussin and Galgani, 2011) . In addition, higher BAT levels are associated with resistance to metabolic diseases (Zhou et al., 2003) . Recent findings that exercise increases the relative amount of BAT (Dunstan, 2011; Boström et al., 2012) have stimulated interest concerning the therapeutic potential of augmenting brown fat to combat metabolic diseases.
PPARα, a member of the peroxisome proliferator-activated receptor (PPAR) family of ligand-activated receptors, can stimulate the expression of the PR domain containing 16 (PRDM16) gene in brown adipocytes, and PPARα activation in white adipocytes has been found to induce the expression of brown fat markers (Yoon, 2009) . A muscle-derived hormone, irisin, has recently been identified as promoting the induction of brown adipocytes in white fat. Investigations at the molecular level have found that one possible mechanism may be increased expression of PPARα, while pharmacological inhibition with a PPARα-selective antagonist limited the induction of the "browning" program by irisin (Castillo-Quan, 2012) . However, the PPARα-agonist WY14643 failed to regulate the expression of the UCP1 gene of white adipocytes unless combined with retinoic acid (RA) (Oberkofler et al., 2002; Mercader et al., 2006; Beranger et al., 2013) .
RA can reduce body weight, increase body temperature, and increase adiposity in rodent models, and stimulates UCP1 expression in brown adipose tissue and skeletal muscle. Furthermore, administration of t-RA results in reduced adiposity and adipocyte cell size with a rise in multilocular adipocytes expressing brown fat markers in white fat depots (Bonet et al., 2012) .
Due to the increasing interest in the mechanisms involved in the transformation of white adipocytes to brown adipocytes, there is an absolute necessity for cellular models to unravel the mechanisms of the PPARα-agonist WY14643, combined with t-RA, on the "browning" of white adipocytes in mice, to help elucidate more mechanistic details.
MATERIAL AND METHODS

Cell culture and differentiation
Mice 3T3-L1 preadipocytes (BOSTER, Wuhan, China) were cultured in growth medium [high glucose Dulbecco's Modified Eagle's Medium (DMEM) containing 1% antibioticantimycotic solution and 10% fetal bovine serum (FBS)] at 37°C in a humidified atmosphere with 5% CO 2 . When reaching confluency, the cells were differentiated in growth medium containing 0.5 mM IBMX (Sigma-Aldrich, America), 1.0 µM dexamethasone (Sigma-Aldrich), and 2 mg/L insulin (Sigma-Aldrich). After 2 days, cells received fresh growth medium containing 2 mg/L insulin. After 4 days, cells received fresh growth medium without additives and cells were replenished with the same medium every 2 days for 8 days. Oil Red O staining for lipid droplets was used to evaluate adipocyte differentiation.
RT-PCR
Cells were plated on six-well plates (8 x 10 4 cells/well) and cultured for 24 h. In treatment 1, the cells were exposed to 2.5 µM, 5 µM, and 10 µM WY14643 (Santa Cruz Biotechnology, USA) for 24 h. In treatment 2, cells were first exposed to 0 mM, 10 -5 mM, 10 -4 mM, 10 -3 mM, 10 -2 mM, and 10 -1 mM t-RA (Sigma-Aldrich) for 24 h. Then, 5 µM WY14643 was added for 24 h. In treatment 3, cells were exposed to 10 µM SB203580 (Santa Cruz Biotechnology) for 24 h, followed by 0 mM, 10 -5 mM, 10 -4 mM, 10 -3 mM, 10 -2 mM, and 10 -1 mM t-RA for 24 h, and finally, 5 µM WY14643 was added for 24 h.
Total RNA was extracted from cells using TRIzol Lysis Reagent (TaKaRa, Japan) according to the manufacturer protocol. First-strand complementary DNA (cDNA) was synthesized using 3 µg total RNA as the template, 500 ng random primer, and the cDNA synthesis kit components (TransGen, Beijing, China) in a total volume of 25 µL, according to the manufacturer protocol. The targeted fragment of cDNA for the brown adipocyte differentiationassociated gene UCP1 (Table 1) was amplified by PCR using 1 µL RT product, 10 pmol each primer, and the PCR premix. 
Gene
Primer sequences
UCP-1, uncoupling protein-1.
Western blot
Cells were exposed to the same three treatments as described in the previous section and then washed 3 times with ice-cold PBS and harvested in ice-cold RIPA buffer containing a protease inhibitor and phosphatase inhibitor cocktail (BOSTER). Protein concentrations were measured with a BCA protein assay kit. Protein was mixed with 5X sample buffer and boiled for 7 min, leaving 25 µL of sample remaining after cooling. The cell lysates were separated by Mechanism of transformation from white to brown adipocytes sodium dodecyl sulfate polyacrylamid gel electrophoresis (SDS-PAGE) and polyvinylidene fluoride (PVDF) membranes. The membranes were blocked with 5% instant skimmed-milk powder, spray-dried in tris-buffered-saline with tween (TBST) for 1 h, and then incubated at 4°C overnight with the appropriate antibody at a 1:1000 dilution in TBS (Anti-phospho-p38 MAPK and anti-p38 MAPK were from CST, USA, anti-UCP1 was from ABgent, USA). After washing, the PVDF membranes were incubated at normal temperature with horseradish peroxidase-conjugated anti-rabbit IgG (Sigma-Aldrich) at a 1:5000 dilution in TBS for 1 h. After washing, images were analyzed using the Image Studio v2.0 software.
Statistical analysis
Results are reported as means ± SD unless otherwise indicated. Data were analyzed using one-way ANOVA and LSD-t tests. Differences were considered to be statistically significant at P < 0.05. The SPSS 17.0 software was used for statistical analyses; P values for significance are indicated for each data set.
RESULTS
Morphology of 3T3-L1 preadipocytes
Before differentiation, mice 3T3-L1 cells were spindle-shaped, with no lipid droplets in the cytoplasm, and had a fibroblast-like morphology ( Figure 1A ). After complete confluence, cells were in growth arrest. After 4 days of differentiation, cells were large and round, with some lipid droplets appearing in some cells. After 8 days of differentiation, preadipocytes were differentiated into mature adipocytes, showing larger, rounder, abundant cytoplasm and a large number of lipid droplets ( Figure 1B and C) . Lipid accumulation was assessed in fixed cells using Oil-red-O staining ( Figure 1D) . These results clearly demonstrate that 3T3-L1 preadipocyte cells differentiated into mature white adipocytes. 
A B C D Role of WY14643 combined with t-RA
Since the white adipocytes of mice do not express UCP1 gene, we examined whether WY14643 combined with t-RA could induce expression of UCP1 gene. In these experiments, we used differentiated mice multipotent adipose-derived 3T3-L1 preadipocytes. Treatment with WY14643 over a range of concentrations from 2.5 to 10 µM was unable to significantly induce transcripts of UCP1 gene; but WY14643 combined with t-RA significantly induced transcripts of UCP1 gene, as shown in Figure 2 E and F.
Western blot analysis ( Figure 2G and H) showed that the ability of WY14643 combined with t-RA to trigger expression was synchronous to the effect of induced phosphorylation of p38 MAPK. Since p38 MAPK activation results in UCP1 production, we assessed the role of p38 MAPK to induce the brown adipocyte marker. However, pretreatment with SB203580, which is a p38 MAPK inhibitor, completely blocked the effect of WY14643 combined with t-RA, suggesting that p38 MAPK activity is important for "browning" of white adipocytes. 
DISCUSSION
Evidence has accumulated that the impact of retinoic acid on developmental and biochemical processes influences mammalian adiposity, including adipocyte differentiation and lipogenesis, adaptive thermogenesis, lipolysis, and fatty acid oxidation in tissues (Bonet et al., 2012) . Treatment with retinoic acid, in particular, has been shown to reduce body fat, improve insulin sensitivity, and induce UCP1 expression in brown adipose tissue and skeletal muscle cells in lean and obese rodents (Mercader et al., 2010) . Retinoic acid has gained increasing attention because of its multiple effects on the biological characteristics of adipocytes, including the impact on the thermogenic capacity of brown fat, and the oxidative and secretory capacity of white fat. t-RA has a role in promoting cell differentiation, distribution of intracellular, and cell's protein synthesis, amino acid uptake and expression of metabolic enzymes (Manolescu et al., 2010) . PPARs (PPARα, PPARβ, and PPARγ) may modulate these metabolic risk factors, suggesting that activation of PPARs may be an effective therapy for several diseases associated with metabolic syndrome. Thus, PPARs have been the subject of intense investigation and considerable pharmacological research (Kliewer et al., 1999; Kersten et al., 2000; Evans et al., 2004) . Studies have shown that PPARα controls a large number of genes related to the metabolism of lipo-protein. PPARα activation also mediates improvements in glucose and energy homeostasis (Pineda et al., 1999) and modulates the expression of UCPs, such as increasing the level of UCP1 mRNA in brown adipose tissue, UCP2 mRNA in liver, and UCP3 mRNA in skeletal muscle (Brun et al., 1999; Barbera et al., 2001; Nakatani et al., 2002) .
WY14643, as a PPARα agonist, has been shown to improve the level of UCP3 mRNA in mice preadipocytes and inhibit free fatty acid synthesizing triglycerides in white adipose tissue, thus, it is involved in the regulation of obesity and lipid metabolism (Cabrero et al., 2000) . However, WY14643 failed to regulate the expression of the UCP1 gene unless combined with retinoic acid, and the mechanism is unknown. Due to the fact that RA impacting on lipid metabolism involves the modulation of the activity of several important protein kinases, for example, the p38 mitogen-activated protein kinase (p38 MAPK) (Lee et al., 2008) , we infer that "browning" of white adipocytes induced by WY14643 combined with t-RA has a relationship with p38 MAPK. In the current study, WY14643 alone, WY14643 combined with t-RA, and WY14643 combined with t-RA and the p38 MAPK inhibitor SB203580 were used to treat white adipocytes from mice. According to the results of the RT-PCR and western blot, WY14643 alone failed to regulate the expression of UCP1. However, WY14643 combined with t-RA induced the expression of UCP1, which could be blocked by pretreatment with SB203580, a p38 MAPK inhibitor. Perhaps this is because p38 MAPK activity is a key link for the "browning" of white adipocytes induced by WY14643. Boström et al. (2012) revealed part of the molecular mechanisms of how exercise promotes the occurrence of "browning." They found that exercise (particularly chronic) is accompanied by increased expression of PGC-1α in muscle. Muscle-specific overexpression of PGC-1α induced a brown-like adipose tissue gene program, including increased UCP1 expression in WAT through stimulation of irisin, a secreted molecule from muscle cells, which was responsible for inducing "browning" of WAT (Boström et al., 2012) . Gene arrays indicated that one possible mechanism of irisin might be increased expression of PPAR-α. Moreover, pharmacological inhibition with a PPAR-α-selective antagonist limited the induction of the "browning" program by irisin (Castillo-Quan, 2012) . Referring to the results of this experiment, activation of the p38 MAPK signaling pathway may be the necessary precondition for activation of PPARα to promote "browning" of white adipocytes. Therefore, we infer that the newfound substance irisin also activates the p38 MAPK signaling pathway in the "browning" program. Whether activation of the p38 MAPK pathway is the precondition for "browning" of white adipocytes in mammal is worth further exploration.
